E&E CONSULTING LTD
Company number 10376319 · Active · London SW16 3PX
E&E CONSULTING LTD is an active private limited company (company number 10376319) incorporated on 15 September 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 30 September 2024, showing net assets of £368k and cash of £471k, with 3 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 241% on the prior period (£108k).
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 15 September 2016
- Next accounts due
- 30 June 2026 — 108 days overdue
- Confirmation statement due
- 29 September 2027 — in 348 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 86210
- General medical practice activities
- Accounts type
- Unaudited Abridged
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 September 2024
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2024 | £368k | £471k | — | £106k | — | — | 3 |
| 30 September 2023 | £108k | £108k | — | — | — | — | 2 |
- Current ratio
- 4.45 — comfortable
- Cash per employee
- £157k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 78/100 (grade B)
- +10 Positive net assets — Net assets £367,646 at 2024-09-30
- +8 Net assets growing — +241.0% vs prior period
- +8 Comfortable liquidity — Current ratio 4.45
- +4 Cash reserves — Cash £471,220
- +8 Established — Incorporated 2016-09-15 (10 years)
- -10 Accounts overdue — Due 2026-06-30
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mrs Elsie Engmann — owns 25–50% of shares; holds 25–50% of voting rights · since 29 September 2025
- Mr Jayden Stanley Lomo Engmann — owns 25–50% of shares · since 29 September 2025
- Mr Emanuel Engmann — owns 50–75% of shares · since 15 September 2016 · ceased 29 September 2025
- Mrs Elsie Engmann — owns 25–50% of shares · since 15 September 2016 · ceased 13 October 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- ESOX BIOLOGICS LTD — London, inc. Sept 2016
- TOWK LIMITED — London, inc. Sept 2016
- ELEUSIS HEALTH SOLUTIONS LTD — Pimlico, inc. Sept 2016
- GLOBAL CLINICAL LIMITED — Islington, inc. Oct 2016
- QUADRUCEPT BIO LIMITED — London, inc. Oct 2016
- DESHAPE LIMITED — London, inc. Oct 2016
Reminders for E&E CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.